HCID 67175763, compound → HCID 44602496, compound
Reaction equation
[Cl:1][C:2]1[CH:38]=[CH:37][C:5]([CH2:6][C:7]2[N:8]=[C:9]([O:33][CH2:34][CH2:35][CH3:36])[C:10]3[N:15]=[C:14]([C:16]4[CH:21]=[C:20]([CH3:22])[C:19]([O:23][CH2:24][CH:25]5[CH2:29][O:28]C(C)(C)[O:26]5)=[C:18]([CH3:32])[CH:17]=4)[O:13][C:11]=3[N:12]=2)=[CH:4][CH:3]=1>ClCCl.FC(F)(F)C(O)=O>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][C:7]2[N:8]=[C:9]([O:33][CH2:34][CH2:35][CH3:36])[C:10]3[N:15]=[C:14]([C:16]4[CH:17]=[C:18]([CH3:32])[C:19]([O:23][CH2:24][CH:25]([OH:26])[CH2:29][OH:28])=[C:20]([CH3:22])[CH:21]=4)[O:13][C:11]=3[N:12]=2)=[CH:37][CH:38]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
The 5-(4-chloro-benzyl)-2-[4-(2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-3,5-dimethyl-phenyl]-7-propoxy-oxazolo[5,4-d]pyrimidine obtained in step (a) was dissolved in 6 ml of dichloromethane and 2 ml of trifluoroacetic acid. The reaction mixture was stirred for 2 h at room temperature. Then the solvents were removed in vacuo and the residue was purified by preparative HPLC (method HPLC1). 4.1 mg of the title compound were obtained.
Workup
- customThen the solvents were removed in vacuo
- customthe residue was purified by preparative HPLC (method HPLC1)
Sources & evidence
- ORD record
- ord-1c430c0b550b491189b340205996a255
- Source dataset
- uspto-grants-2014_05
- Patent number
- US08735387B2
Reaction notes
Loading…